PerkinElmer (NYSE: PKI) and Thermo Fisher Scientific (NYSE:TMO) are both mid-cap computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations.
Institutional and Insider Ownership
91.7% of PerkinElmer shares are owned by institutional investors. Comparatively, 83.5% of Thermo Fisher Scientific shares are owned by institutional investors. 2.2% of PerkinElmer shares are owned by insiders. Comparatively, 0.5% of Thermo Fisher Scientific shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Volatility and Risk
PerkinElmer has a beta of 0.74, suggesting that its share price is 26% less volatile than the S&P 500. Comparatively, Thermo Fisher Scientific has a beta of 1.05, suggesting that its share price is 5% more volatile than the S&P 500.
PerkinElmer pays an annual dividend of $0.28 per share and has a dividend yield of 0.4%. Thermo Fisher Scientific pays an annual dividend of $0.60 per share and has a dividend yield of 0.3%. PerkinElmer pays out 8.5% of its earnings in the form of a dividend. Thermo Fisher Scientific pays out 10.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. PerkinElmer is clearly the better dividend stock, given its higher yield and lower payout ratio.
This is a summary of current ratings and target prices for PerkinElmer and Thermo Fisher Scientific, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Thermo Fisher Scientific||0||1||14||1||3.00|
PerkinElmer presently has a consensus target price of $66.91, suggesting a potential downside of 2.66%. Thermo Fisher Scientific has a consensus target price of $193.36, suggesting a potential upside of 0.89%. Given Thermo Fisher Scientific’s stronger consensus rating and higher probable upside, analysts clearly believe Thermo Fisher Scientific is more favorable than PerkinElmer.
Valuation and Earnings
This table compares PerkinElmer and Thermo Fisher Scientific’s revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|PerkinElmer||$2.14 billion||3.54||$416.05 million||$3.31||20.77|
|Thermo Fisher Scientific||$19.20 billion||3.89||$4.81 billion||$5.74||33.39|
Thermo Fisher Scientific has higher revenue and earnings than PerkinElmer. PerkinElmer is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.
This table compares PerkinElmer and Thermo Fisher Scientific’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Thermo Fisher Scientific||11.80%||15.97%||7.48%|
Thermo Fisher Scientific beats PerkinElmer on 12 of the 17 factors compared between the two stocks.
PerkinElmer Company Profile
PerkinElmer, Inc. is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets. It provides analytical instrumentation for the industrial market, which includes the chemical, electronics, energy, lubricant, petrochemical and polymer industries. Its products include AAnalyst, Altus, Aquamatic, Avio, AxION, Clarus, DairyGuard, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, Cell carrier and cell::explorer. The Diagnostics segment is focused on reproductive health, emerging market diagnostics and applied genomics. Its products include AutoDELFIA, BACS-on-Beads, Bioo Scientific, BoBs, Datalytix, Dexela, Dexela CMOS FPDs, Evolution, ViaCord, and Zephyr.
Thermo Fisher Scientific Company Profile
Thermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables. The Analytical Instruments segment provides a range of instruments, consumables, software and services. The Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. The Laboratory Products and Services segment offers controlled temperature technologies products, growth protection and separation products, and water and laboratory products.
Receive News & Ratings for PerkinElmer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer Inc. and related companies with MarketBeat.com's FREE daily email newsletter.